MariMed (OTCQB:MRMD) announced its client Kind Therapeutics successfully passed the Maryland Cannabis Commission compliance inspection of its newly renovated facility designed and developed by MariMed and has commenced cultivation in Hagerstown Maryland.
As quoted in the press release:
MariMed acquired the 180,000 sq. ft. property, which had been vacant for a decade, and renovated it into a secure, state of the art cannabis cultivation and production facility. MariMed has leased the facility to Kind Therapeutics, which is expected to employ up to 100 staff and have capacity to produce over two tons of high quality organic cannabis medicine.
Utilizing MariMed’s proven practices and procedures, Kind’s team has successfully begun cultivation of its first cannabis crop. Kind expects to distribute and sell cannabis medicine and products from its first harvest throughout Maryland in the first quarter of 2018.